Company Filing History:
Years Active: 2024
Title: Da Bee Jeon: Innovator in Influenza Treatment
Introduction
Da Bee Jeon is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing influenza virus diseases. His innovative approach focuses on utilizing monoclonal antibodies to combat these viral infections.
Latest Patents
Da Bee Jeon holds 1 patent for his invention titled "Dosing regimen for treating influenza virus diseases." This patent describes a method for treating influenza-related diseases through the administration of a mixed composition of monoclonal antibodies that possess neutralizing activity against the influenza A virus. The treatment method allows for intravenous administration, providing a promising solution to unmet medical needs for biological therapeutic agents targeting influenza virus-related diseases.
Career Highlights
Da Bee Jeon is associated with Celltrion Inc., a company known for its advancements in biopharmaceuticals. His work at Celltrion has positioned him as a key player in the development of innovative treatments for viral infections.
Collaborations
He collaborates with esteemed colleagues, including Sung Hyun Kim and Hyun Chul An, who contribute to the research and development efforts within the company.
Conclusion
Da Bee Jeon's contributions to the field of influenza treatment through his innovative patent highlight his role as a significant inventor in the medical industry. His work continues to pave the way for advancements in therapeutic solutions for viral diseases.